What Else Can Big Pharma Do?
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Dr. Larry Kaskel is joined by Kathleen Slattery-Moschkau, former drug rep turned award-winning filmaker. They will discuss alternative ways pharma can educate physicians about new drugs.
Overview
Dr. Larry Kaskel is joined by Kathleen Slattery-Moschkau, former drug rep turned award-winning filmaker. They will discuss alternative ways pharma can educate physicians about new drugs.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Evolving Our View of the Coagulation Cascade and Stroke Management
I'm Getting the Hang of This! I Have Two Patients: One At 'Indeterminate Risk' and One At 'High Risk' for Clinically Significant Fibrosis
Maximizing Adherence and Persistence via Patient Engagement
Love Story: Lipid Education for Women’s Heart Health
HF Management for Patients with Comorbid Conditions
Clinical Conundrums in ARIA: 1. Navigating the Baseline MRI for Anti-Aβ Monoclonal Antibodies
Clinical Conundrums in ARIA: Communicating ARIA Risk with Patients Considering Anti-Aβ Therapy
Impact of Barostim on Heart Failure Hospitalization
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?